PHOSBLOCK Side Effects

5466096-3 | Blood Alkaline Phosphatase Increased, Oral Intake Reduced
on Sep 05, 2007 Male patient from JAPAN , 55 years of age, was diagnosed with hyperphosphataemia and was treated with Phosblock (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, oral intake reduced. Phosblock dosage: 250 Mg Qd Po. During the same period patient was treated with PRECIPIATED CALCIUM CARBONATE (View Precipiated Calcium Carbonate Review and Precipiated Calcium Carbonate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), TICLOPIDINE HYDROCHLORIDE (View Ticlopidine Hydrochloride Review and Ticlopidine Hydrochloride Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ).

5058480-7 | Diarrhoea, Diverticulitis, Diverticulum Intestinal Haemorrhagic, Enteritis, Gastritis Erosive, Gastrointestinal Haemorrhage, Haemoglobin Decreased, Stress At Work
Patient was taking Phosblock (View Usage). Patient had the following side effects: diarrhoea, diverticulitis, diverticulum intestinal haemorrhagic, enteritis, gastritis erosive, gastrointestinal haemorrhage, haemoglobin decreased, stress at work on Jul 05, 2006 from JAPAN Additional patient health information: Male patient , 61 years of age, was diagnosed with hyperphosphataemia and. Phosblock dosage: 0.75 G Daily Po. During the same period patient was treated with HERBAL MEDICINE (View Herbal Medicine Review and Herbal Medicine Label ), ETHYL (ICOSAPENTATE) (View Ethyl (icosapentate) Review and Ethyl (icosapentate) Label ), RANITIDINE HYDROCHLORIDE (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ), TEPRENONE (View Teprenone Review and Teprenone Label ), PRECIPITATED CALCIUM CARBONATE (View Precipitated Calcium Carbonate Review and Precipitated Calcium Carbonate Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), FEXOFENADINE HYDROCHLORIDE (View Fexofenadine Hydrochloride Review and Fexofenadine Hydrochloride Label ). Patient was hospitalized.

4817586-5 | Acute Myocardial Infarction, Constipation, Dyspnoea, Headache
Adverse event was reported on Oct 17, 2005 by a Male patient taking Phosblock (View Usage) (Dosage: 7.5 G Daily Po) was diagnosed with hyperphosphataemia and. Location: JAPAN , 48 years of age, weighting 176.4 lb, After Phosblock was administered, patient had the following side effects: acute myocardial infarction, constipation (What is constipation?), dyspnoea, headache (What is headache?). During the same period patient was treated with CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), SODIUM PICOSULFATE (View Sodium Picosulfate Review and Sodium Picosulfate Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ETHYL ICOSAPENTATE (View Ethyl Icosapentate Review and Ethyl Icosapentate Label ), TRIAZOLAM (View Triazolam Review and Triazolam Label ). Patient was hospitalized.

4775011-7 |
on Sep 01, 2005 Male patient from JAPAN , 62 years of age, was treated with Phosblock (View Usage). . Phosblock dosage: .


4746621-8 | Anaemia, Duodenal Ulcer, Feeling Abnormal, Gastrointestinal Haemorrhage
on Jul 29, 2005 Male patient from JAPAN , 48 years of age, was diagnosed with hyperphosphataemia, back pain (What is back pain?) and was treated with Phosblock (View Usage). Patient had the following side effects: anaemia, duodenal ulcer, feeling abnormal, gastrointestinal haemorrhage. Phosblock dosage: 2 G Qd Po. During the same period patient was treated with DICLOFENAC SODIUM (50 Mg Qd Po) (View Diclofenac Sodium Review and Diclofenac Sodium Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ), DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ), HYDROXYZINE PAMOATE (View Hydroxyzine Pamoate Review and Hydroxyzine Pamoate Label ), EPOETIN ALFA (View Epoetin Alfa Review and Epoetin Alfa Label ). Patient was hospitalized.

4730159-8 | Anaemia, Faeces Hard, Haemorrhage, Large Intestine Perforation, Tremor
Patient was taking Phosblock (View Usage). After Phosblock was administered, patient had the following side effects: anaemia, faeces hard, haemorrhage, large intestine perforation, tremor on Jul 14, 2005 from JAPAN Additional patient health information: Female patient , 57 years of age, was diagnosed with hyperphosphataemia and. Phosblock dosage: 0.25 G Tid Po. During the same period patient was treated with GIGOXIN (View Gigoxin Review and Gigoxin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PRECIPITATED CALCIUM CARBONATE (View Precipitated Calcium Carbonate Review and Precipitated Calcium Carbonate Label ), VERAPAMIL HYDROCHLORIDE (View Verapamil Hydrochloride Review and Verapamil Hydrochloride Label ), TEPRENONE (View Teprenone Review and Teprenone Label ), D SORBITOL (View D-sorbitol Review and D-sorbitol Label ), TELMISARTAN (View Telmisartan Review and Telmisartan Label ).

4720856-2 | Abdominal Pain Lower, Constipation, Faeces Hard, Peritoneal Haemorrhage, Peritonitis, Rectal Perforation
Adverse event was reported on Jul 05, 2005 by a Male patient taking Phosblock (View Usage) (Dosage: 6 G Qd Po) was diagnosed with hyperphosphataemia, hyperkalaemia and. Location: JAPAN , 51 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain lower, constipation (What is constipation?), faeces hard, peritoneal haemorrhage, peritonitis, rectal perforation. During the same period patient was treated with CALCIUM POLYSTYRENE SULFONATE (50 G Qd Po) (View Calcium Polystyrene Sulfonate Review and Calcium Polystyrene Sulfonate Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), TERMISARTAN (View Termisartan Review and Termisartan Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), MEXILETINE HCL (View Mexiletine Hcl Review and Mexiletine Hcl Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), CILAZAPRIL (View Cilazapril Review and Cilazapril Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ).

4703412-1 | Faecaloma, Fluid Intake Reduced, Haemodialysis, Large Intestine Perforation, Melaena
on Jun 14, 2005 Female patient from , 70 years of age, was diagnosed with hyperphosphataemia and was treated with Phosblock (View Usage). Patient had the following side effects: faecaloma, fluid intake reduced, haemodialysis, large intestine perforation, melaena. Phosblock dosage: 6 G Daily Po. During the same period patient was treated with PHOSBLOCK 250 MG TABLETS (3 G Daily Po) (View Phosblock - 250 Mg Tablets Review and Phosblock - 250 Mg Tablets Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), AMEZINIUM METILSULFATE (View Amezinium Metilsulfate Review and Amezinium Metilsulfate Label ), CALCIUM POLYSTYRENE SULFONATE (View Calcium Polystyrene Sulfonate Review and Calcium Polystyrene Sulfonate Label ), TRIAZOLAM (View Triazolam Review and Triazolam Label ), AMLODIPINE BESILATE (View Amlodipine Besilate Review and Amlodipine Besilate Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

4692358-3 | Large Intestine Perforation
on Jun 01, 2005 Female patient from , 70 years of age, was diagnosed with hyperphosphataemia and was treated with Phosblock (View Usage). After Phosblock was administered, patient had the following side effects: large intestine perforation. Phosblock dosage: 6 G Daily Po. During the same period patient was treated with CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), AMEZINIUM METILSULFATE (View Amezinium Metilsulfate Review and Amezinium Metilsulfate Label ), CALCIUM POLYSTYRENE SULFONATE (View Calcium Polystyrene Sulfonate Review and Calcium Polystyrene Sulfonate Label ), TRIAZOLAM (View Triazolam Review and Triazolam Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ). Patient was hospitalized.

4659534-7 | Atrial Fibrillation, Blood Pressure Systolic Decreased, Depressed Level Of Consciousness, Dizziness, Hyperkalaemia, Malaise, Sinus Bradycardia, Ventricular Tachycardia
Patient was taking Phosblock (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), blood pressure systolic decreased, depressed level of consciousness, dizziness (What is dizziness?), hyperkalaemia, malaise, sinus bradycardia, ventricular tachycardia on Apr 28, 2005 from Additional patient health information: Male patient , 65 years of age, was diagnosed with hyperphosphataemia and. Phosblock dosage: 0.5 G Bid Po. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), TEPRENONE (View Teprenone Review and Teprenone Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

4615943-3 | Pneumonia
Adverse event was reported on Mar 07, 2005 by a Male patient taking Phosblock (View Usage) (Dosage: 1.5 G Daily Po) was diagnosed with hyperphosphataemia and. Location: , 44 years of age, Patient had the following side effects: pneumonia (What is pneumonia?). Patient was hospitalized.

4603976-2 | Gastroenteritis Viral, Haemodialysis
on Feb 22, 2005 Female patient from , 62 years of age, was diagnosed with hyperphosphataemia and was treated with Phosblock (View Usage). After Phosblock was administered, patient had the following side effects: gastroenteritis viral, haemodialysis. Phosblock dosage: 0.75 G Qd Po. During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), MECOBALAMIN (View Mecobalamin Review and Mecobalamin Label ), NEUROTROPINE (View Neurotropine Review and Neurotropine Label ), FLURBIPROFEN (View Flurbiprofen Review and Flurbiprofen Label ), UREA (View Urea Review and Urea Label ). Patient was hospitalized.

4592457-0 | Cholelithiasis, Diverticulitis, Diverticulum Intestinal
on Feb 07, 2005 Male patient from , 57 years of age, was diagnosed with hyperphosphataemia and was treated with Phosblock (View Usage). Patient experienced the following unwanted or unexpected effects: cholelithiasis, diverticulitis, diverticulum intestinal. Phosblock dosage: 2 G Tid Po. During the same period patient was treated with EPOETIN BETA (View Epoetin Beta Review and Epoetin Beta Label ), BLUTAL (View Blutal Review and Blutal Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), DIHYDROCODEINE BITARTRATE INJ (View Dihydrocodeine Bitartrate Inj Review and Dihydrocodeine Bitartrate Inj Label ), CHLORPHENIRAMINE MATEATE (View Chlorpheniramine Mateate Review and Chlorpheniramine Mateate Label ). Patient was hospitalized.

4592454-5 | Abdominal Pain, Anaemia, Constipation, Hepatic Function Abnormal, Renal Haemorrhage
Patient was taking Phosblock (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), anaemia, constipation (What is constipation?), hepatic function abnormal, renal haemorrhage on Feb 07, 2005 from Additional patient health information: Female patient , 71 years of age, was diagnosed with hyperphosphataemia and. Phosblock dosage: 0.25 G Tid Po. During the same period patient was treated with EPOETIN ALPHA (View Epoetin Alpha Review and Epoetin Alpha Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ), TEPRENONE (View Teprenone Review and Teprenone Label ). Patient was hospitalized.